Ignite Creation Date:
2024-05-06 @ 8:26 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06383858
Status:
RECRUITING
Last Update Posted:
2024-04-25
First Post:
2024-04-14
Brief Title:
The Project of Gestational Hypertension and Preeclampsia Screening and Prevention Center
Sponsor:
The Third Affiliated Hospital of Guangzhou Medical University
Organization:
The Third Affiliated Hospital of Guangzhou Medical University
Study Overview
Official Title:
The Project of Gestational Hypertension and Preeclampsia Screening and Prevention
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Preeclampsia is the main cause of illness and death in pregnant women and fetuses Currently there is no effective treatment for preeclampsia in clinical practice and the fundamental treatment is still termination of pregnancy and placental delivery
Therefore early prediction of preeclampsia and targeted strengthening of high-risk pregnant women supervision early intervention and diagnosis and treatment can greatly reduce the serious obstetric complications and perinatal maternal and fetal deaths caused by preeclampsia which has significant social and clinical significance
Therefore early prediction of preeclampsia and targeted strengthening of high-risk pregnant women supervision early intervention and diagnosis and treatment can greatly reduce the serious obstetric complications and perinatal maternal and fetal deaths caused by preeclampsia which has significant social and clinical significance
Detailed Description:
The purpose of this study is to evaluate the influence of pre-eclampsia risk screening scheme based on maternal high-risk factors or pre-eclampsia risk assessment and management plan based on placental growth factor PIGF detection in the real medical world on the incidence of pre-eclampsia maternal mortality and severe complications of pre-eclampsia and to establish appropriate pre-eclampsia risk screening and prevention standards and guidelines for China population so as to reduce the probability of maternal and fetal death and long-term chronic diseases
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None